RainDrop assay using 4 μL of genomic DNA Concentration of amplifiable DNA ≥ 50 ng? Copies/assay ≥ 10? T790M positive T790M negative reRainDrop assay using.

Slides:



Advertisements
Similar presentations
Figure 1. Live/Dead assay of cells in High Insulin+Col II bead shows high mortality. The above figure shows the Live/Dead assay taken of cells in an example.
Advertisements

Chemometrics Method comparison
Supplementary file 3 Concentration of the plasmid containing a single copy of MusaSAP1 5’ UTR : 50 ng/μl Total length of the plasmid containing a single.
Genome Analysis of Latin American Cervical Cancer: Frequent Activation of the PIK3CA Pathway Supplementary Data Files in this Data Supplement: Supplementary.
Supplemental data 2. Breast cancer primary tumor, metastasis and xenograft Total copy number gain (green), loss (red) and unchanged (black) for primary.
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia Nature Genetics.
B Supplementary Figure S1A. Pre-amplification preserves mutant allele frequency and maintains sensitivity of ESR1-D538G mutation detection by ddPCR. A-B.
Supplementary Figure S1 Inhibition of AKT and S6 phosphorylation. After 4 h treatment with 1 µM of GDC-0941, EVSA-T parental, resistant Clone1, Clone2,
A B Supplementary Figure S1. T790M CTC PointMan genotyping assay. (A) Test characteristics of PointMan CTC T790M genotyping assay. The assay was validated.
Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet.
Detection of Exon 12 Mutations in the JAK2 Gene
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma  Daniela Drandi, Lenka Kubiczkova-Besse,
Quantitative Detection and Resolution of BRAF V600 Status in Colorectal Cancer Using Droplet Digital PCR and a Novel Wild-Type Negative Assay  Roza Bidshahri,
A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma  Karen L. Reckamp, MD, Vladislava O. Melnikova,
Comparative Analysis of Single-Cell RNA Sequencing Methods
Locked Nucleic Acids Can Enhance the Analytical Performance of Quantitative Methylation-Specific Polymerase Chain Reaction  Karen S. Gustafson  The Journal.
Single-Color Digital PCR Provides High-Performance Detection of Cancer Mutations from Circulating DNA  Christina Wood-Bouwens, Billy T. Lau, Christine.
A Method to Evaluate the Quality of Clinical Gene-Panel Sequencing Data for Single- Nucleotide Variant Detection  Chung Lee, Joon S. Bae, Gyu H. Ryu, Nayoung.
FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor  Anniina Färkkilä, Melissa K. McConechy,
Nienke van der Stoep, James R Gorman, Frederick W Alt  Immunity 
A Quantitative Allele-Specific PCR Test for the BRAF V600E Mutation Using a Single Heterozygous Control Plasmid for Quantitation  Philippe Szankasi, N.
Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy  Yuka Igarashi, Toru Uchiyama, Tomoko Minegishi, Sirirat.
Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations  Nuria Mencia-Trinchant,
MethySYBR, a Novel Quantitative PCR Assay for the Dual Analysis of DNA Methylation and CpG Methylation Density  Pang-Kuo Lo, Hanano Watanabe, Pi-Chun.
Clinical Application of Picodroplet Digital PCR Technology for Rapid Detection of EGFR T790M in Next-Generation Sequencing Libraries and DNA from Limited.
Elena Castellanos-Rizaldos, Cloud Paweletz, Chen Song, Geoffrey R
Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice  Stephan Bartels, Sascha Persing, Britta Hasemeier,
Daniel Chi-Hong Lin, Alan D Grossman  Cell 
Jianbin Wang, H. Christina Fan, Barry Behr, Stephen R. Quake  Cell 
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Volume 38, Issue 4, Pages (May 2010)
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Clinical Relevance of Sensitive and Quantitative STAT3 Mutation Analysis Using Next- Generation Sequencing in T-Cell Large Granular Lymphocytic Leukemia 
A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples  Prashanth Setty, Jennifer Hammes, Thomas Rothämel, Valentina.
Quantification of the Mutant CALR Allelic Burden by Digital PCR
Two-Dimensional Substructure of MT Receptive Fields
Volume 7, Issue 5, Pages (November 2016)
A, relationship between weighted mean chromosome copy number and weighted Genome Instability Index (wGII). A, relationship between weighted mean chromosome.
Detection of Exon 12 Mutations in the JAK2 Gene
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies  Michael J. Kluk, R. Coleman Lindsley,
Comprehensive Diagnostic Testing for Stereocilin
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia  Claudia Brunetti, Luisa Anelli, Antonella.
Analytical Validation of Clinical Whole-Genome and Transcriptome Sequencing of Patient-Derived Tumors for Reporting Targetable Variants in Cancer  Kazimierz.
Volume 7, Issue 1, Pages (April 2014)
Volume 14, Issue 19, Pages (October 2004)
NGS on SOP-generated HRV-16-specific sequence from pure and mixed samples is slightly less sensitive than quantitative real-time RT-PCR (qrRT-PCR). NGS.
Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell–Free DNA from Patients with Advanced Non–Small Cell.
Volume 9, Issue 3, Pages (March 2006)
Figure 1. Plasma next-generation sequencing (NGS) assay workflow, comparison of variant allelic fraction with ... Figure 1. Plasma next-generation sequencing.
Design and Evaluation of a Real-Time PCR Assay for Quantification of JAK2 V617F and Wild-Type JAK2 Transcript Levels in the Clinical Laboratory  Jason.
High-Throughput Identification and Quantification of Candida Species Using High Resolution Derivative Melt Analysis of Panfungal Amplicons  Tasneem Mandviwala,
Development of an Allele-Specific Real-Time PCR Assay for Discrimination and Quantification of p63 R279H Mutation in EEC Syndrome  Vanessa Barbaro, Letizia.
Low Incidence of Minor BRAF V600 Mutation-Positive Subclones in Primary and Metastatic Melanoma Determined by Sensitive and Quantitative Real-Time PCR 
Pierre-Henri L Gaillard, Eishi Noguchi, Paul Shanahan, Paul Russell 
A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer  Zengliu Su, Dora Dias-Santagata,
Energetics of Pore Opening in a Voltage-Gated K+ Channel
Analysis of GFP expression in gfp loss-of-function mutants.
A Transient Histone Hyperacetylation Signal Marks Nucleosomes for Remodeling at the PHO8 Promoter In Vivo  Hans Reinke, Philip D. Gregory, Wolfram Hörz 
A B C D G G/A Figure 1. Sequencing reveals mosaicism for point mutation. A. Sequencing shows a homozygous c.862 G>A mutation in the DNA from tumor of unilaterally.
Effect of cxcr3.2 mutation on dissemination of local mycobacterial infection within 24 hpi. Effect of cxcr3.2 mutation on dissemination of local mycobacterial.
The oligoclonal antibody overcomes the C797S mutation‐mediated resistance to osimertinib The oligoclonal antibody overcomes the C797S mutation‐mediated.
Equivalent Parental Contribution to Early Plant Zygotic Development
Volume 49, Issue 5, Pages (March 2013)
Volume 9, Issue 2, Pages (August 1998)
Rapid pathogen-specific phenotypic antibiotic susceptibility testing using digital LAMP quantification in clinical samples by Nathan G. Schoepp, Travis.
Plasma and tissue EGFR allele analyses.
Volume 8, Issue 2, Pages (August 2003)
Detection of mutant alleles using ddPCR.
Molecular Therapy - Nucleic Acids
Integrated analysis of gene expression and copy number alterations.
Presentation transcript:

RainDrop assay using 4 μL of genomic DNA Concentration of amplifiable DNA ≥ 50 ng? Copies/assay ≥ 10? T790M positive T790M negative reRainDrop assay using 8 μL of genomic DNA Yes No Yes No Copies/assay ≥ 10? T790M positive Yes T790M negative No Flowchart for mutation call. If the measured event in the T790M gate was ≥ 10 events/assay, the assay was considered to be “positive”. If the event within a gated region was < 10 events/assay, the assay was considered to be “negative”. An assay was inconclusive if the amount of amplifiable DNA was less than 50 ng, at which point then a further assay was performed using 8 μL of DNA (double the volume of the initial assay). Supplementary Figure S1Watanabe et al.

Supplementary Figure S2 Quantification of performance of ddPCR analysis for EGFR T790M mutation. Plasmid containing the EGFR T790M mutation (MT plasmid: 2,000, 200, 20, or 0 copy) were serially diluted in 200,000 copies of wild-type EGFR sequence- containing plasmid (WT plasmid). Plasmids were encapsulated into droplets and subjected to the procedure described in Fig. 1. (A) Two-dimensional histogram of ddPCR assay. FAM, 6-carboxyfluorescein; TET, tetrachlorofluorescein. (B) After ddPCR assay, the copy numbers of spiked T790M mutant plasmid were counted using RainDrop Analyst software. Each filled circle represents an individual data point (n = 3). The dotted lines above and below the regression line (straight black line) display the 95% confidence interval. (C) Identical serial dilutions ranging from 0.01–1.00% T790M mutation copies per reaction were assayed in triplicates. The correlation coefficient (R 2 ) is given on the graph. Data shown here are representative of two independent experiments for each assay. WT plasmid: 2 × × × × 10 5 MT plasmid: 2 × × × EGFR_wt-TET EGFR_T790M-FAM T790M WT T790M WT T790M WT T790M WT A BC Observed copy# (copies/sample) Expected copy# (copies/sample) Observed mutant% Expected mutant% Watanabe et al.

Supplementary Figure S3 Analytical sensitivity of 0.001% for the ddPCR assay. Twenty (2 × 10 1 ) copies of mutant plasmid were spiked into 2 × 10 6 copies of wild-type plasmid, resulting in 0.001% of the mutational fractional abundance. Spiked and non-spiked samples analyzed using the ddPCR assay. (A) Two-dimensional histogram of the non-spiked (left) and the spiked (right) assays. (B) Table showing wild-type and mutant events in both samples. (C) Mutant event is shown in box plot for spiked and non-spiked samples. Box indicates the range of the 95% confidence interval, and the line inside the box indicates the mean. Lines above and below the box denote maximum and minimum events, respectively. A BC WT plasmid: 2 × × 10 6 MT plasmid: - 2 × 10 1 EGFR_wt-TET T790M WT EGFR_T790M-FAM T790M WT WT plasmid: 2 ×10 6 MT plasmid: - WT plasmid: 2 ×10 6 MT plasmid: 2 ×10 1 Wild-type copies T790M copies Wild-type copies T790M copies #11,996, ,995, #21,996, ,996, #31,995, ,996, #42,254, ,167, #52,214, ,242, #62,237, ,306, Mean % CI WT plasmid: 2 × × 10 6 MT plasmid: - 2 × 10 1 T790M copies/assay p < 0.01 (Wilcoxon test) Watanabe et al.

EGFR_wt-TET EGFR_T790M -FAM Wild-type control plasmid Human genomic DNA T790M WT T790M WT A549 genomic DNA T790M WT Determination of false-positive events from wild-type control DNA and normal human genomic DNA. Two- dimensional histogram of ddPCR assay with 2 × 10 5 wild-type control plasmid DNA (left), 400 ng human genomic DNA (middle), and 400 ng A549 genomic DNA (right). Supplementary Figure S4Watanabe et al.

InputA549 genomic DNA from FFPE cell block (400 ng) Sample # Amplifiable DNA (ng) Wild-type events False positive events # # # # # # # # Event 26.8 Mean 3.35 Std % Upper Limit (One-tail Poisson Dist.) 7 Watanabe et al. EGFR_wt-TETEGFR_T790M -FAM T790M WT Determination of false-positive events in genomic DNA from formalin-fixed paraffin-embedded (FFPE) A549 cells. (A) Two-dimensional histogram of ddPCR assay with 400 ng genomic DNA form FFPE A549 cell block. (B) Determination of the limit of blank (LOB) from the 95% confidence interval of the Poisson model fit. Supplementary Figure S5 AB A549 gDNA from FFPE cell block

EGFR_wt-TET EGFR_T790M-FAM JME ng JME ng JME ng JME ng JME ng 98.8% 98.7% 99.3% 98.9% 98.5% T790M WT T790M WT T790M WT T790M WT T790M WT Supplementary Figure S6Watanabe et al. Detection of EGFR T790M mutant alleles in patients with EGFR T790M-containing primary tumors. Two- dimensional histogram of ddPCR assay with genomic DNA from FFPE samples. Sample ID and amount of input DNA are indicated on plots. Percentages of empty drops are also displayed on the plot, indicating that > 98% of drops are empty.

Operator 2 (% of MT allele) Operator 1 (% of MT allele) Supplementary Figure S7Watanabe et al. Comparison of T790M mutation detection in 6 samples by different operators. Operator-to-operator variation of T790M mutant events in DNA samples from 6 T790M-positive cases. The slope and correlation coefficient are given in the graph.

Operator 2 (% of MT allele) Operator 1 (% of MT allele) Supplementary Figure S8Watanabe et al. Reproducibility of ddPCR analysis from 16 T790M-positive samples. ddPCR assay was performed on different days by two different operators to confirm the reproducibility of the percentage of mutant allele. The slope and correlation coefficient are given in the graph.